BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer
-
Published:2024-02
Issue:
Volume:
Page:
-
ISSN:1526-8209
-
Container-title:Clinical Breast Cancer
-
language:en
-
Short-container-title:Clinical Breast Cancer
Author:
Liao Muheng,
Webster Jace,
Coonrod Emily M.,
Weilbaecher Katherine N.,
Maher Christopher A.,
White Nicole M.ORCID
Funder
Emerson Collective
Reference32 articles.
1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022
2. Gene expression profiling in breast cancer: classification, prognostication, and prediction;Reis-Filho;Lancet Lond Engl,2011
3. A closer look at estrogen receptor mutations in breast cancer and their implications for estrogen and antiestrogen responses;Clusan;Int J Mol Sci,2021
4. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients;Wenger;Breast Cancer Res Treat,1993
5. Biological subtypes of breast cancer: prognostic and therapeutic implications;Yersal;World J Clin Oncol,2014